Bcl-2 level as a biomarker for 13q14 deletion in CLL

BACKGROUND: Deletion 13q14.3 is the most common cytogenetic abnormality in chronic lymphocytic leukemia (CLL). Previously it was reported that miR-15/16 is the target of 13q14 deletions and plays a tumor suppressor role by suppressing Bcl-2. Therefore, Bcl-2 expression was examined more closely to d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Degheidy, Heba A., Gadalla, Shahinaz M., Farooqui, Mohammed Z.H., Abbasi, Fatima, Arthur, Diane C., Bauer, Steven R., Wilson, Wyndham H., Wiestner, Adrian, Stetler-Stevenson, MA., Marti, Gerald E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3963274/
https://ncbi.nlm.nih.gov/pubmed/23674504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.b.21090
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares